|
|
LBA33 5-year overall survival (OS) in patients (pts) with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN) treated with xevinapant + chemoradiotherapy (CRT) vs placebo + CRT in a randomized, phase II study
J. Bourhis
,
C. Le Tourneau
,
B. Calderon
,
L. Martin
,
C. Sire
,
et al.
Article dans une revue
hal-03911292v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
TACE and conformal radiotherapy vs. TACE alone for hepatocellular carcinoma: A randomised controlled trial
Cyrille Féray
,
Loic Campion
,
Philippe Mathurin
,
Isabelle Archambreaud
,
Xavier Mirabel
,
et al.
Article dans une revue
hal-04044132v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
A Pragmatic Study Evaluating NEPA Versus Aprepitant for Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Moderately Emetogenic Chemotherapy
Laurent Zelek
,
Philippe Debourdeau
,
Hugues Bourgeois
,
Jean Philippe Wagner
,
Fabien Brocard
,
et al.
Article dans une revue
hal-03598654v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Extended follow-up of a phase 2 trial of xevinapant plus chemoradiotherapy in high-risk locally advanced squamous cell carcinoma of the head and neck: a randomised clinical trial
Yungan Tao
,
Xu-Shan Sun
,
Yoann Pointreau
,
Christophe Le Tourneau
,
Christian Sire
,
et al.
Article dans une revue
hal-04002440v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Practical and technical key challenges in head and neck adaptive radiotherapy: The GORTEC point of view
Nolwenn Delaby
,
Anaïs Barateau
,
Sophie Chiavassa
,
Marie-Claude Biston
,
Philippe Chartier
,
et al.
Article dans une revue
hal-04061410v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|